Toshitsugu Oka

Author PubWeight™ 11.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Poorly differentiated neuroendocrine carcinoma of the seminal vesicle. Int J Urol 2011 1.40
2 Elevated expression of valosin-containing protein (p97) is associated with poor prognosis of prostate cancer. Clin Cancer Res 2004 1.21
3 Clinical outcome and prognostic factors of sorafenib in Japanese patients with advanced renal cell carcinoma in general clinical practice. Jpn J Clin Oncol 2011 1.06
4 Needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer. Brachytherapy 2009 0.83
5 [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution]. Jpn J Antibiot 2006 0.82
6 Assessment of daily needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer using daily CT examinations. J Radiat Res 2012 0.81
7 Expression of Epstein-Barr virus in renal cell carcinoma. Oncol Rep 2007 0.80
8 High-dose-rate interstitial brachytherapy in combination with androgen deprivation therapy for prostate cancer: are high-risk patients good candidates? Strahlenther Onkol 2014 0.79
9 [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). III. Secular changes in susceptibility]. Jpn J Antibiot 2006 0.78
10 New ambulatory implant technique of high-dose-rate interstitial brachytherapy for prostate cancer. Radiat Med 2006 0.77
11 [Solitary fibrous tumor of the urinary bladder: a case report]. Nihon Hinyokika Gakkai Zasshi 2012 0.77
12 New implant technique for separation of the seminal vesicle and rectal mucosa for high-dose-rate prostate brachytherapy. Brachytherapy 2007 0.77
13 [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2003). III. Secular changes in susceptibility]. Jpn J Antibiot 2005 0.76
14 Seminal vesicle metastasis of renal cell carcinoma. Urology 2009 0.75
15 [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2002). III. Secular changes in susceptibility]. Jpn J Antibiot 2004 0.75
16 [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004) II. Background of patients]. Jpn J Antibiot 2006 0.75
17 [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2000). I. Susceptibility distribution]. Jpn J Antibiot 2002 0.75
18 [Prostate cancer metastasized to thyroid cartilage: a case report]. Nihon Hinyokika Gakkai Zasshi 2005 0.75
19 [Comparative studies on activities on antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2000). III. Secular changes in susceptibility]. Jpn J Antibiot 2002 0.75
20 [Validation of 2009 TNM classification based on a prognostic analysis of 350 patients treated for renal cell carcinoma]. Nihon Hinyokika Gakkai Zasshi 2012 0.75
21 [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2002). I. Susceptibility distribution]. Jpn J Antibiot 2004 0.75
22 [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2001). III. Secular changes in susceptibility]. Jpn J Antibiot 2003 0.75
23 [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2001). II. Background of patients]. Jpn J Antibiot 2003 0.75
24 Combined surgical treatment for localized prostate cancer and incidental ureteral duplication with ectopic ureter inserting into the prostatic urethra. Int J Urol 2012 0.75
25 [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2003). II. Background of patients]. Jpn J Antibiot 2005 0.75
26 [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2000). II. Background of patients]. Jpn J Antibiot 2002 0.75
27 [Hyperprolactinemia and erectile dysfunction]. Nihon Rinsho 2002 0.75
28 [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2003). I. Susceptibility distribution]. Jpn J Antibiot 2005 0.75
29 [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2002). II. Background of patients]. Jpn J Antibiot 2004 0.75
30 [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2001). I. Susceptibility distribution]. Jpn J Antibiot 2003 0.75